CYTOKINETICS, INCORPORATEDCytokinetics, Incorporated • December 2nd, 2011 • Cytokinetics Inc • Pharmaceutical preparations
Unless otherwise defined herein, the terms defined in the Cytokinetics, Incorporated 2004 Equity Incentive Plan (the “Plan”) shall have the same defined meanings in this Restricted Stock Unit Award Agreement (the “Agreement”).
CYTOKINETICS, INCORPORATED and U.S. BANK NATIONAL ASSOCIATION as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of November 13, 2019 4.00% Convertible Senior Notes due 2026Cytokinetics, Incorporated • November 13th, 2019 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS SUPPLEMENTAL INDENTURE, dated as of November 13, 2019 (the “Supplemental Indenture”), to the Indenture, dated as of November 13, 2019 (the “Base Indenture” and, as amended, modified and supplemented by this Supplemental Indenture, the “Indenture”), between Cytokinetics, Incorporated, a Delaware corporation, as issuer (the “Company”) and U.S. Bank National Association, as trustee (the “Trustee”).
CYTOKINETICS, INCORPORATED and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of July 6, 2022 3.50% Convertible Senior Notes due 2027Cytokinetics, Incorporated • July 6th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of July 6, 2022, between Cytokinetics, Incorporated, a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
